Archives: Speakers

In this role, Gary leads W2’s product, marketing, design and innovation teams in Newport to develop and design the company’s products that are used by their clients millions of times every month. Prior to W2, Gary has worked in senior product roles for the likes of Bottomline Technologies, Autotrader and the Number 118118.

Ms. Jovonni Spinner is a public health strategist and thought leader with a deep passion for improving health equity across the lifespan through research, communication, multi-sector partnerships, and leadership coaching. She is known as a public health programming guru using her skills to direct projects from concept to fully operational through program design, implementation, monitoring and evaluation, and breaking down silos across sectors.

At the Food and Drug Administration, she is the Lead for the Outreach and Communications Team in the Office of Minority Health overseeing the strategic direction of the team, advising senior officials on minority health, and leading the Diversity in Clinical Trials Initiative. Prior to joining FDA, she managed national initiatives including the Community Health Worker Health Disparities Initiative, which aims to reduce cardiovascular and asthma health disparities through community education and training at the National Institutes of Health-National Heart, Lung and Blood Institute. She also provided health policy guidance to leaders on vaccine supply and finance policy issues at the HHS, National Vaccine Program Office, and served as the Director of Virginia’s Vaccines for Children Program ensuring the state’s Medicaid, uninsured, and underinsured populations were vaccinated.

She serves on non-profit boards; American Public University System and Society for Public Health Education, and writes women’s health articles for Health in Her Hue.

Ms. Spinner received her Bachelor’s degree in Biology from Virginia Commonwealth University, Master’s of Public Health from Emory University-Rollins School of Public Health and is pursuing her Doctorate of Public Health from Morgan State University.

Pharmaceutical professional with 20 years experience in managing global clinical supply chain activities including strategic planning and forecasting of clinical supply budgets, FTE’s, supply requirements and IRT development. Also responsible for managing and maintaining relationships with CRO’s, distribution vendors, suppliers, and packaging vendors.

Alfredo D’Addio – Director, Strategic Operations, Global Investigational Material Supply Chain at Celgene Corporation.

Over 14 years of experience in the Pharmaceutical industry in the area of Global Supply. A wealth of knowledge in the development lifecycle and interdependencies of the clinical supply chain to set strategies and proactively identify risks involved. Well versed with negotiation tactics to leverage partnerships/vendors, establish long-range objectives to develop strategies needed to achieve them. A solid background in forecasting & demand planning provides strong ability to identify gaps and implement solutions to gain efficiencies, while maintaining product quality. Thrives on setting short- and long-term strategies that proactively identifies challenges and implement solutions to minimize risk to the organization and to ensure patients have continuous access to therapies.

Bachelor of Science degree in Business Management at Fairleigh Dickinson University and has a Graduate Certificate in Pharmaceutical & Medical Device Law & Compliance from Seaton Hall School of Law.

Judy is a Nurse and has 20+ years in the Pharmaceutical Industry with various roles and for the past 7 years in  Biopharmaceutical and Medical Device Research & Development with Windtree Therapeutics, Inc.   She is currently overseeing the clinical team, closing 2 clinical trials and preparing for the next Phase 2 Clinical Trial that will hopefully launch into Phase 3 shortly thereafter.